Get the Stockscreener App
4.52
2.96%
+0.13
After Hours:
4.52
Achieve Life Sciences Inc. stock is currently priced at $4.52, with a 24-hour trading volume of 456.40K.
It has seen a +2.96% increased in the last 24 hours and a -1.31% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $4.46 pivot point. If it approaches the $4.53 resistance level, significant changes may occur.
Previous Close:
$4.39
Open:
$4.43
24h Volume:
456.40K
Market Cap:
$154.82M
Revenue:
-
Net Income/Loss:
$-29.82M
P/E Ratio:
-1.4534
EPS:
-3.11
Net Cash Flow:
$-24.50M
1W Performance:
-0.44%
1M Performance:
-1.31%
6M Performance:
+5.85%
1Y Performance:
-47.38%
1D Range:
$4.43
$4.76
52W Range:
$3.03
$10.30
Achieve Life Sciences Inc. Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc.
Sector
Industry
Phone
425-686-1500
Address
19820 North Creek Parkway, Suite 201, Bothell, BC
Achieve Life Sciences Inc. Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc. Stock (ACHV) Latest News
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
GlobeNewswire Inc.
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
GlobeNewswire Inc.
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
GlobeNewswire Inc.
Crude Oil Down 4%; Aditxt Shares Spike Higher
Benzinga
Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results
Benzinga
Achieve Life Sciences Inc. Stock (ACHV) Financials Data
Achieve Life Sciences Inc. (ACHV) Net Income 2024
ACHV net income (TTM) was -$29.82 million for the quarter ending December 31, 2023, a +29.60% increase year-over-year.
Achieve Life Sciences Inc. (ACHV) Cash Flow 2024
ACHV recorded a free cash flow (TTM) of -$24.50 million for the quarter ending December 31, 2023, a +34.79% increase year-over-year.
Achieve Life Sciences Inc. (ACHV) Earnings per Share 2024
ACHV earnings per share (TTM) was -$1.51 for the quarter ending December 31, 2023, a +62.81% growth year-over-year.
Achieve Life Sciences Inc. Stock (ACHV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JACOBS CINDY | President & CMO |
Apr 19 '24 |
Option Exercise |
0.00 |
16,250 |
0 |
34,511 |
| Stewart Richard Alistair | Executive Chairman |
Apr 19 '24 |
Option Exercise |
0.00 |
22,500 |
0 |
61,001 |
| Bencich John | CEO |
Apr 19 '24 |
Option Exercise |
0.00 |
25,000 |
0 |
101,724 |
| Stewart Richard Alistair | Executive Chairman |
Mar 04 '24 |
Buy |
4.58 |
10,000 |
45,850 |
38,501 |
| Bencich John | CEO |
Mar 04 '24 |
Buy |
4.58 |
10,000 |
45,850 |
76,724 |
| Bencich John | CEO |
May 30 '23 |
Buy |
5.50 |
5,000 |
27,500 |
66,730 |
About Achieve Life Sciences Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has a license agreement with Sopharma AD and University of Bristol. The company is headquartered in Bothell, Washington.
3.18%
Cap:
|
Volume (24h):